FDAnews Drug Daily Bulletin

ALDER BIOPHARMACEUTICALS INC. FORMS COLLABORATION WITH SCHERING-PLOUGH

Dec. 5, 2005
A A

Alder Biopharmaceuticals Inc., an emerging antibody therapeutics company, today announced a broad collaborative alliance with Schering-Plough, a leading pharmaceutical company. The collaboration will use Alder's proprietary yeast production system and high throughput antibody selection system to identify and produce antibodies more rapidly and cost effectively. Under terms of the agreement, Alder will work on up to ten Schering-Plough antibody products.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1118107XSL_NEWSML_TO_NEWSML_WEB.xml)